AE Wealth Management’s Apellis Pharmaceuticals APLS Stock Holding History

AE Wealth Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,316	Closed	-$495K	–	2667
2026 Q1	$495K	Buy	+12,316	New	+$265K	﹤0.01%	1120

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AE Wealth Management's APLS Position: Q2 2026 in Review

AE Wealth Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 12,316 shares — an estimated $495K sold.

AE Wealth Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $495K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

AE Wealth Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AE Wealth Management sold 12,316 Apellis Pharmaceuticals shares in Q2 2026, an estimated $495K.
AE Wealth Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AE Wealth Management's Apellis Pharmaceuticals position peaked at $495K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.